Sept 20 (Reuters) - Allergan Plc CEO Brent Saunders
calls them "stepping stones" - small, bolt-on acquisitions, as
opposed to the mega-deals common in the drug industry. And
they're expected to boost dealmaking in sectors ranging from
neurology to skin care.
Read more
No comments:
Post a Comment